Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Davis

Davis Opportunity Fund Class A (RPEAX)

Ticker RPEAX · · Holdings as of Jun 30, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+11.4%annualized
1-yr return
+16.2%as of Dec 2025
Net assets
$652.0Mall share classes
Holdings
51

Bottom line

Is RPEAX a good fund? The bottom line

RPEAX is the Class A share class of Davis Opportunity Fund, an actively managed large blend mutual fund from Davis.

Annual fees run 0.94% — about $94 a year on every $10,000 invested, more expensive than 59% of large blend funds we track.

It returned +16.2% over one year, +11.4% a year over five years, +11.6% a year over ten (as of Dec 31, 2025, per its prospectus).

With $652 million in net assets and 51 holdings, its largest position is Quest Diagnostics Inc (6.6%) and the top 10 make up 44.5% of the portfolio.

This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Front-end sales load up to 4.75%
  • 12b-1 marketing fee of 0.22% a year

Updated Nov 19, 2026

What RPEAX invests in

The Fund seeks long-term growth of capital.

Davis Selected Advisers, L.P. (Davis Advisors or the Adviser), the Funds investment adviser, uses the Davis Investment Discipline to invest the Funds portfolio principally in common stocks (including indirect holdings of common stock through Depositary Receipts (as defined below)). The Fund may invest in large, medium or small companies without regard to market capitalization and may invest in issuers in foreign countries, including countries with developed or emerging markets. Davis Investment Discipline. Davis Advisors manages equity funds using the Davis Investment Discipline. Davis Advisors conducts extensive research to try to identify businesses that possess characteristics that Davis Advisors believes foster the creation of long-term value, such as proven management, a durable franchise and business model, and sustainable competitive advantages. Davis Advisors aims to invest in…

From the fund's prospectus (filed Apr 29, 2026).

RPEAX performance

Fund calendar-year total returns, 2016–2025 2016: +15.3%; 2017: +23.1%; 2018: −13.5%; 2019: +25.5%; 2020: +12.8%; 2021: +25.0%; 2022: −14.1%; 2023: +22.1%; 2024: +12.8%; 2025: +22.0% +15% 2016 +23% 2017 −14% 2018 +25% 2019 +13% 2020 +25% 2021 −14% 2022 +22% 2023 +13% 2024 +22% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
RPEAX+16.2%+11.4%+11.6%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full RPEAX performance history →

What RPEAX costs

On a $10,000 investment, RPEAX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,575 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full RPEAX fee table →

RPEAX top 10 holdings

#Holding% of fund
1Quest Diagnostics Inc DGX6.59%
2Viatris Inc VTRS6.25%
3Wesco International Inc WCC6.07%
4Devon Energy Corp DVN4.13%
5Cvs Health Corp CVS4.04%
6Mgm Resorts International MGM4.02%
7Solventum Corp SOLV3.60%
8Capital One Financial Corp COF3.35%
9Stonex Repo3.28%
10US Bancorp USB3.14%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 44.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to RPEAX

More funds like RPEAX →

RPEAX FAQ

What is the expense ratio of RPEAX?
RPEAX's expense ratio is 0.94%, which works out to about $94 a year for every $10,000 invested. The prospectus estimates total costs of $1,575 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RPEAX a good investment?
It depends on your goals, but the data points to: front-end sales load up to 4.75%; 12b-1 marketing fee of 0.22% a year. This is general information, not personalized advice.
What does RPEAX hold?
RPEAX's largest holdings are Quest Diagnostics Inc (6.6%), Viatris Inc (6.2%), Wesco International Inc (6.1%), Devon Energy Corp (4.1%), Cvs Health Corp (4.0%). It holds 51 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RPEAX's 5-year return?
RPEAX returned +11.4% a year over the five years ending Dec 31, 2025, and +11.6% a year over ten years. Past performance does not guarantee future results.
Does RPEAX have a sales load?
Yes. RPEAX has a maximum front-end sales charge of 4.75%. It may charge a deferred sales charge of up to 0.5% if sold early.
Who manages RPEAX?
RPEAX is offered by Davis through Davis Series Inc.